Nexus BioPharma's Incubator/Accelerator Round

Nexus BioPharma raised a round of funding on February 01, 2017. Investors include JLabs.

Nexus BioPharma is a preclinical stage biotechnology company developing new therapies and intellectual property from research and development activities for treating obesity and type 2 diabetes. Nexus…

Articles about Nexus BioPharma's Incubator/Accelerator Round: